Hwanin Lithium Carbonate Tablets

Adult dose

Adults: Administer 0.6-1.8g of lithium carbonate per day orally in 3 divided doses. Adjust the dose as appropriate according to age and symptoms.

This medication can become toxic if blood lithium levels are elevated, so facilities for rapid and accurate measurement of blood lithium levels are necessary during treatment. While taking this medication, there may be abnormalities in the electrocardiogram, so caution should be exercised, particularly in patients suspected of having Brugada syndrome. Consultation with a cardiologist should be done before administration. This medication should not be given to patients with brain disorders, cardiovascular diseases, impaired kidney function, dehydration, symptoms such as fever or diarrhea, those on sodium intake restriction, patients taking specific diuretics or serotonin agonists, pregnant women, and patients with Addison's disease. Caution is required for patients with a history of heart disease, elderly patients, and those with liver or thyroid dysfunction. Those allergic to Yellow No. 4 included in this medication should also use it cautiously. During use, symptoms of lithium toxicity may appear, such as nausea, vomiting, diarrhea, dizziness, confusion, muscle twitching, so if any abnormal symptoms arise, consult a doctor immediately. Dizziness or drowsiness may occur; therefore, it is advised to avoid driving vehicles or operating dangerous machinery while taking this medication. Blood lithium levels should be regularly monitored, and if levels become too high, the dosage should be reduced or stopped. When taken with other psychiatric and neurological medications, toxicity symptoms may worsen, so careful monitoring should be done according to a doctor's instructions when used together. Co-administration with specific diuretics, anticonvulsants, antipsychotics, anti-inflammatory analgesics, antidepressants, etc., can affect lithium levels, so it is essential to inform the prescriber of any co-administered medications. Women who are pregnant or may become pregnant should not take this medication, and nursing mothers should avoid it or discontinue breastfeeding while on it. Safety in children has not been established, so health care providers should be consulted as needed. Elderly patients may experience increased blood lithium levels due to decreased kidney function, so conditions should be observed carefully before administration. This medication should be kept out of the reach of children, and transferring it to another container may negatively affect quality, so caution is necessary.

nausea, vomiting, diarrhea, loss of appetite, dysphagia, tremor, muscle spasms, motor dysfunction, ataxia, weakness, hypokinesia, rigidity, dizziness, fever, sweating, speech impairment, confusion, headache, tinnitus, blurred vision, gaze disturbance, nystagmus, hypertonia, hypotonia, dysarthria, anxiety, hallucinations, consciousness disorder, memory impairment, incontinence, convulsive seizures, abnormal EEG, arrhythmia, hypotension, abnormal ECG, leukocytosis, urine retention, oliguria, dehydration, confusion, coma, abnormal EEG, dizziness, fever, headache, sensory disturbances, rigidity, insomnia, speech impairment, forgetfulness, memory impairment, restlessness, urinary incontinence, scotoma, chills, tinnitus, drowsiness, dysuria, convulsive seizures, hypokinesia, emotional instability, confusion, confusion, coma, tremor, hypertonia, hypotonia, dysarthria, ataxia, myoclonus, chorea-athetosis, abnormal ECG, hypotension, tachycardia, arrhythmia, peripheral circulation disorder, Brugada syndrome, polyuria, dysuria, oliguria, frequency of urination, proteinuria, diabetes, renal function abnormalities, liver function abnormalities, nausea, vomiting, thirst, loss of appetite, abdominal pain, gastrointestinal disturbances, diarrhea, constipation, excessive salivation, leukocytosis, skin rash, itching, folliculitis, lower extremity ulcers, numbness, dry and brittle hair, systemic symptoms, drug reaction with eosinophilia and systemic symptoms (DRESS), decreased T3, decreased T4, decreased PBI, increased thyroid 131I uptake, increased TSH response after TRH loading, non-toxic goiter, mucinous edema, thyrotoxicosis, primary hyperparathyroidism, parathyroid adenoma, hypercalcemia, blurred vision, basic wave confusion, increased delta wave, reversible lethargy, T-wave inversion, weakness, fatigue, weight gain, weight loss, edema, scotoma, decreased libido, elevated blood sugar, dehydration

This medication should be stored in a tightly closed container to prevent air or moisture ingress. It is advisable to maintain a storage temperature between 1°C and 30°C.

Appearance

Yellow circular tablets

Package unit

For domestic use) 500 tablets/bottle, for export) 30 tablets (10 tablets/PTP×3), 50 tablets/bottle